AWS
BIIB icon

Atria Wealth Solutions’s Biogen BIIB Stock Holding History

Atria Wealth Solutions’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,620
Closed -$248K – 1879
2024
Q4 		$248K Sell
1,620
-44
-3% -$7.42K ﹤0.01% 1671
2024
Q3 		$323K Sell
1,664
-21
-1% -$4.39K ﹤0.01% 1471
2024
Q2 		$391K Sell
1,685
-5
-0.3% -$1.09K ﹤0.01% 1356
2024
Q1 		$364K Sell
1,690
-836
-33% -$196K ﹤0.01% 1419
2023
Q4 		$654K Sell
2,526
-58
-2% -$14.2K 0.01% 1073
2023
Q3 		$664K Sell
2,584
-425
-14% -$114K 0.01% 1004
2023
Q2 		$857K Buy
3,009
+65
+2% +$19.3K 0.01% 909
2023
Q1 		$819K Sell
2,944
-10
-0.3% -$2.77K 0.01% 884
2022
Q4 		$818K Buy
2,954
+724
+32% +$204K 0.01% 851
2022
Q3 		$595K Sell
2,230
-67
-3% -$14.2K 0.01% 933
2022
Q2 		$468K Buy
2,297
+1,061
+86% +$217K 0.01% 999
2022
Q1 		$260K Buy
+1,236
New +$269K ﹤0.01% 1394

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Atria Wealth Solutions's BIIB Position: Q1 2025 in Review

Atria Wealth Solutions sold out of Biogen (BIIB) in Q1 2025, closing a stake of 1,620 shares — an estimated $248K sold.

Atria Wealth Solutions first reported a position in BIIB in Q1 2022 and held it in 12 quarters. The position peaked at $857K in Q2 2023. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Atria Wealth Solutions reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Atria Wealth Solutions sold 1,620 Biogen shares in Q1 2025, an estimated $248K.
  • Atria Wealth Solutions first reported a position in Biogen in Q1 2022 and held it in 12 quarters.
  • Atria Wealth Solutions's Biogen position peaked at $857K in Q2 2023.
  • 883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Atria Wealth Solutions's 13F filing for Q1 2025, filed 9 May 2025.